351 related articles for article (PubMed ID: 34807906)
1. Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden.
Ankarfeldt MZ; Petersen J; Andersen JT; Li H; Motsko SP; Fast T; Hede SM; Jimenez-Solem E
PLoS Med; 2021 Nov; 18(11):e1003851. PubMed ID: 34807906
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
[TBL] [Abstract][Full Text] [Related]
3. Risk of adverse birth outcomes after maternal varenicline use: A population-based observational study in Denmark and Sweden.
Pedersen L; Petronis KR; Nørgaard M; Mo J; Frøslev T; Stephansson O; Granath F; Kieler H; Sørensen HT
Pharmacoepidemiol Drug Saf; 2020 Jan; 29(1):94-102. PubMed ID: 31713302
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
[No Abstract] [Full Text] [Related]
5. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.
Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O
Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807
[TBL] [Abstract][Full Text] [Related]
6. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death.
Pasternak B; Svanström H; Mølgaard-Nielsen D; Melbye M; Hviid A
JAMA; 2013 Oct; 310(15):1601-11. PubMed ID: 24129464
[TBL] [Abstract][Full Text] [Related]
7. Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy.
Eck LK; Jensen TB; Mastrogiannis D; Torp-Pedersen A; Askaa B; Nielsen TK; Poulsen HE; Jimenez-Solem E; Andersen JT
Obstet Gynecol; 2017 Apr; 129(4):707-714. PubMed ID: 28277353
[TBL] [Abstract][Full Text] [Related]
8. Nitrosatable drug exposure during pregnancy and risk of stillbirth.
Thomsen AML; Liew Z; Riis AH; Stayner LT; Ramlau-Hansen CH; Sigsgaard T; Olsen J
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1204-1210. PubMed ID: 31348585
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
[TBL] [Abstract][Full Text] [Related]
10. Reproductive life in women with celiac disease; a nationwide, population-based matched cohort study.
Grode L; Bech BH; Plana-Ripoll O; Bliddal M; Agerholm IE; Humaidan P; Ramlau-Hansen CH
Hum Reprod; 2018 Aug; 33(8):1538-1547. PubMed ID: 29912336
[TBL] [Abstract][Full Text] [Related]
11. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies.
Bérard A; Sheehy O; Zhao JP; Gorgui J; Bernatsky S; de Moura CS; Abrahamowicz M
CMAJ; 2019 Feb; 191(7):E179-E187. PubMed ID: 30782643
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study.
Ankarfeldt MZ; Petersen J; Andersen JT; Fernandes MFS; Li H; Motsko SP; Fast T; Jimenez-Solem E
Drugs Real World Outcomes; 2021 Sep; 8(3):289-299. PubMed ID: 34008161
[TBL] [Abstract][Full Text] [Related]
13. Exposure to antidepressants during pregnancy--prevalences and outcomes.
Jimenez-Solem E
Dan Med J; 2014 Sep; 61(9):B4916. PubMed ID: 25186551
[TBL] [Abstract][Full Text] [Related]
14. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
Lassen D; Ennis ZN; Damkier P
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
17. In utero exposure to antibiotics and risk of congenital malformations: a population-based study.
Damkier P; Brønniche LMS; Korch-Frandsen JFB; Broe A
Am J Obstet Gynecol; 2019 Dec; 221(6):648.e1-648.e15. PubMed ID: 31260651
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
19. Birth outcomes after exposure to mebendazole and pyrvinium during pregnancy - A Danish nationwide cohort study.
Torp-Pedersen A; Jimenez-Solem E; Cejvanovic V; Poulsen HE; Andersen JT
J Obstet Gynaecol; 2016 Nov; 36(8):1020-1025. PubMed ID: 27189319
[TBL] [Abstract][Full Text] [Related]
20. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.
Wogelius P; Nørgaard M; Gislum M; Pedersen L; Munk E; Mortensen PB; Lipworth L; Sørensen HT
Epidemiology; 2006 Nov; 17(6):701-4. PubMed ID: 17028507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
